Difference between revisions of "Zhu J, et al. Biochem. Biophys. Res. Commun. (2017) cited as Ref 166 in DOI: 10.1038/s41392-020-0110-5 (Q9429)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 482, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Wnt/beta-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Wnt/beta-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells (English) | ||
| Property / title: Wnt/beta-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:53, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zhu J, et al. Biochem. Biophys. Res. Commun. (2017) cited as Ref 166 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zhu J
0 references
2017
0 references
Biochem. Biophys. Res. Commun.
0 references
482
0 references
Wnt/beta-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells (English)
0 references
